• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices

  • Print
  • Share
  • E-mail
-

The inventory of GRAS notices provides information about GRAS notices filed since 1998, when FDA received its first GRAS notice. As of October 17, 2016, the GRAS final rule (81 FR 54960; August 17, 2016) requires a specific format for a GRAS notice. Prior to that date, FDA processed GRAS notices under the framework of the GRAS proposed rule (62 FR 18938; April 17, 1997). Notices received prior to the effective date of the GRAS final rule provide examples for potential notifiers for the types of information that may support a GRAS conclusion. In the inventory, notices follow the requirements for the format and content of a GRAS notice as of the effective date of the GRAS final rule.

The inventory notes what type of response letter the FDA sent in response to the notice. Notifiers often resubmit notices that FDA previously ceased to evaluate at the notifier’s request, and resubmitted notices commonly receive a letter indicating FDA has no questions, after addressing deficiencies. In the inventory, entries for notices that were later resubmitted link to the newer entry in the final column. Newer entries for notices that were resubmitted include a link to the previous submission below the substance name.

Some GRNs that FDA previously ceased to evaluate at the notifier’s request were later resubmitted as a food additive petition. For each of these cases, the GRN detail page links to the food additive petition.

After issuing a response letter, we may issue a subsequent letter as circumstances warrant. The issue dates of any subsequent letters are listed under the column, "Date of add’l correspondence.”

As of July 2025, FDA is posting notices in a Docket at www.regulations.gov. In these cases, the link for the notices will take you to the document posted at www.regulations.gov. We will update this information approximately monthly. More information about this inventory is available on the GRAS Notice Inventory Introduction page.


Search and display hints:

  • Select the specific GRN number below to view additional details about any GRAS Notice.
  • To sort by a specific field, click on the column header for that field.
  • To browse the records, use the Show All, First/Previous/Next/Last, and Jump To options at the bottom of the data table.
  • To search for a specific substance/term, enter the term in the Search box and select Show Items to display only those records that contain the selected term. (The search results also includes terms not shown on this page, but included in the full record on the detail page.)
  • The search results will return hits of records containing words that include the search term. For example, a search for the color red will return results that include terms such as reduce, ingredient, and cultured. To limit results to only the searched term, place a space before and after the word in the basic search or in the advanced search “this exact phrase” field.
Download GRAS Notices data in Microsoft Excel web format Download data from this searchable database in Excel format. If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Search within these results
Records Found: 20 Page 1 of 1
GRN No.
(sorted Z-A)
Substance Date of closure FDA's Letter Date of add'l correspondence Resubmitted as GRN No.
  921
3'-sialyllactose sodium salt Oct 30, 2020 FDA has no questions (in PDF) (771 kB)
  919
Lacto-N-neotetraose Oct 30, 2020 FDA has no questions (in PDF) (353 kB)
  911
Rebaudioside I Jun 8, 2021 FDA has no questions (in PDF) (208 kB)
  857
Phospholipase A1 produced by Aspergillus niger Dec 20, 2019 FDA has no questions (in PDF) (465 kB)
  672
Preparation containing five bacterial monophages specific to Shigella spp. Mar 27, 2017 FDA has no questions (in PDF) (109 kB)
  656
Enzyme-modified steviol glycosides Sep 28, 2016 FDA has no questions
  526
Bacillus coagulans strain Unique IS2 spores preparation Mar 23, 2015 FDA has no questions
  503
Tamarind seed polysaccharide Aug 12, 2014 FDA has no questions
  502
Lactobacillus acidophilus La-14 Aug 19, 2014 FDA has no questions
  435
Preparation consisting of six bacterial monophage specific to Salmonella enterica (monophage cocktail) Feb 22, 2013 FDA has no questions Jan 17, 2024
Jun 28, 2021
Nov 15, 2019
Feb 13, 2015
  413
Beta glucans derived from Ganoderma lucidum mycelium Aug 10, 2012 FDA has no questions
  354
Rebaudioside A purified from the leaves of Stevia rebaudiana (Bertoni) Bertoni (rebaudioside A) Jul 15, 2011 FDA has no questions
  248
Sucrose fatty acid esters (i.e., sucrose monoesters of lauric acid, palmitic acid, and stearic acid) manufactured by reaction of sucrose with vinyl esters of lauric, palmitic, and stearic acids Oct 24, 2008 FDA has no questions
  246
Isomalto-oligosaccharide mixture
   (Resubmission of GRN 172)
Feb 10, 2009 FDA has no questions Jun 1, 2016
  244
Glutathione May 9, 2008 At the notifier's request, FDA ceased to evaluate this notice
  293
  163
Tomato pulp powder Aug 8, 2005 FDA has no questions Sep 15, 2010
Jan 26, 2007
  39
Tall oil phytosterols Apr 24, 2000 FDA has no questions Nov 2, 2000
  38
Cetylpyridinium chloride
   (Resubmission of GRN 31)
Feb 29, 2000 Notice does not provide a basis for a GRAS determination
  37
Whey protein isolate and dairy product solids Apr 21, 2000 FDA has no questions Jan 30, 2001
  36
Chromium picolinate; Ginkgo biloba leaf extract; and Ginseng extract Apr 10, 2000 At the notifier's request, FDA ceased to evaluate this notice

GRN No.
(sorted Z-A)
Substance Date of closure FDA's Letter Date of add'l correspondence Resubmitted as GRN No.
-
-